Chronic Lyme Disease: A Review

Infectious Disease Clinics of North America

Volumn 22, Issue 2, 2008, Pages 341-360

  Marques, Adriana ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; DOXYCYCLINE; PENICILLIN V; PLACEBO;

ANTIBIOTIC THERAPY; ARTHRALGIA; BORRELIA BURGDORFERI; CLINICAL TRIAL; COGNITIVE DEFECT; FATIGUE; HEADACHE; HUMAN; INCIDENCE; INSOMNIA; IRRITABILITY; LYME DISEASE; MENINGITIS; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL PAIN; NONHUMAN; PARESTHESIA; REVIEW; SYMPTOM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; HUMANS; LYME DISEASE; SYNDROME;

EID: 42949083634     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.12.011     Document Type: Review

References (78)

1. Feder Jr. H.M., Johnson B.J., O'Connell S., et al. A critical appraisal of chronic Lyme disease. N Engl J Med 357 14 (2007) 1422-1430
2. Marshall E. Lyme disease. Patients scarce in test of long-term therapy. Science 283 5407 (1999) 1431
3. Krupp L.B., Hyman L.G., Grimson R., et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double-masked clinical trial. Neurology 60 12 (2003) 1923-1930
4. Fallon B.A., Keilp J.G., Corbera K.M., et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology (2007) [epub ahead of print]
5. Sigal L.H. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med 88 6 (1990) 577-581
6. Steere A.C., Taylor E., McHugh G.L., et al. The overdiagnosis of Lyme disease. JAMA 269 14 (1993) 1812-1816
7. Rose C.D., Fawcett C.T., Gibney K.M., et al. The overdiagnosis of Lyme disease in children residing in an endemic area. Clin Pediatr 33 11 (1994) 663-668
8. Feder Jr. H.M., and Hunt M.S. Pitfalls in the diagnosis and treatment of Lyme disease in children. JAMA 274 1 (1995) 66-68
9. Reid M.C., Schoen R.T., Evans J., et al. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 128 5 (1998) 354-362
10. Qureshi M.Z., New D., Zulqarni N.J., et al. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr Infect Dis J 21 1 (2002) 12-14
11. Smith R.P., Schoen R.T., Rahn D.W., et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 136 6 (2002) 421-428
12. Nowakowski J., Nadelman R.B., Sell R., et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med 115 2 (2003) 91-96
13. Wormser G.P., Ramanathan R., Nowakowski J., et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138 9 (2003) 697-704
14. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 9 (2006) 1089-1134
15. Dattwyler R.J., Halperin J.J., Volkman D.J., et al. Treatment of late Lyme borreliosis-randomised comparison of ceftriaxone and penicillin. Lancet 1 8596 (1988) 1191-1194
16. Pfister H.W., Preac-Mursic V., Wilske B., et al. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis 163 2 (1991) 311-318
17. Steere A.C., Levin R.E., Molloy P.J., et al. Treatment of Lyme arthritis. Arthritis Rheum 37 6 (1994) 878-888
18. Kalish R.A., Kaplan R.F., Taylor E., et al. Evaluation of study patients with Lyme disease, 10- to 20-year follow-up. J Infect Dis 183 3 (2001) 453-460
19. Kindstrand E., Nilsson B.Y., Hovmark A., et al. Peripheral neuropathy in acrodermatitis chronica atrophicans-effect of treatment. Acta Neurol Scand 106 5 (2002) 253-257
20. Berglund J., Stjernberg L., Ornstein K., et al. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 34 6 (2002) 421-425
21. Dattwyler R.J., Wormser G.P., Rush T.J., et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr 117 11-12 (2005) 393-397
22. Borg R., Dotevall L., Hagberg L., et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 37 6-7 (2005) 449-454
23. Oksi J., Nikoskelainen J., Hiekkanen H., et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26 8 (2007) 571-581
24. Steere A.C., and Glickstein L. Elucidation of Lyme arthritis. Nat Rev Immunol 4 2 (2004) 143-152
25. Weber K., Preac-Mursic V., Neubert U., et al. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann N Y Acad Sci 539 (1988) 324-345
26. Strle F., Preac-Mursic V., Cimperman J., et al. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection 21 2 (1993) 83-88
27. Dattwyler R.J., Luft B.J., Kunkel M.J., et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 337 5 (1997) 289-294
28. Picha D., Moravcova L., Lasikova S., et al. Symptoms of post-Lyme syndrome in long-term outcome of patients with neuroborreliosis. Scand J Infect Dis 38 8 (2006) 747-748
29. Steere A.C., Hutchinson G.J., Rahn D.W., et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 99 1 (1983) 22-26
30. Dattwyler R.J., Volkman D.J., Conaty S.M., et al. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 336 8728 (1990) 1404-1406
31. Weber K., Preac-Mursic V., Wilske B., et al. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 18 2 (1990) 91-96
32. Shadick N.A., Phillips C.B., Logigian E.L., et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 121 8 (1994) 560-567
33. Asch E.S., Bujak D.I., Weiss M., et al. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 21 3 (1994) 454-461
34. Salazar J.C., Gerber M.A., and Goff C.W. Long-term outcome of Lyme disease in children given early treatment. J Pediatr 122 4 (1993) 591-593
35. Gerber M.A., Shapiro E.D., Burke G.S., et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 335 17 (1996) 1270-1274
36. Wang T.J., Sangha O., Phillips C.B., et al. Outcomes of children treated for Lyme disease. J Rheumatol 25 11 (1998) 2249-2253
37. Adams W.V., Rose C.D., Eppes S.C., et al. Cognitive effects of Lyme disease in children: a 4-year follow-up study. J Rheumatol 26 5 (1999) 1190-1194
38. Arnez M., Radsel-Medvescek A., Pleterski-Rigler D., et al. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans. Wien Klin Wochenschr 111 22-23 (1999) 916-922
39. Seltzer E.G., Gerber M.A., Cartter M.L., et al. Long-term outcomes of persons with Lyme disease. JAMA 283 5 (2000) 609-616
40. Arnez M., Pleterski-Rigler D., Luznik-Bufon T., et al. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. Wien Klin Wochenschr 114 13-14 (2002) 498-504
41. Eppes S.C., and Childs J.A. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 109 6 (2002) 1173-1177
42. Thorstrand C., Belfrage E., Bennet R., et al. Successful treatment of neuroborreliosis with ten-day regimens. Pediatr Infect Dis J 21 12 (2002) 1142-1145
43. Hickie I., Davenport T., Wakefield D., et al. Postinfective and chronic fatigue syndromes precipitated by viral and nonviral pathogens: prospective cohort study. BMJ 333 7568 (2006) 575
44. Picavet H.S., and Schouten J.S. Musculoskeletal pain in the Netherlands: prevalences, consequences, and risk groups, the DMC(3)-study. Pain 102 1-2 (2003) 167-178
45. Aggarwal V.R., McBeth J., Zakrzewska J.M., et al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?. Int J Epidemiol 35 2 (2006) 468-476
46. Morphy H., Dunn K.M., Lewis M., et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 30 3 (2007) 274-280
47. Rohrbeck J., Jordan K., and Croft P. The frequency and characteristics of chronic widespread pain in general practice: a case-control study. Br J Gen Pract 57 535 (2007) 109-115
48. Wang T.J., Liang M.H., Sangha O., et al. Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease. Clin Infect Dis 31 5 (2000) 1149-1154
49. Klempner M.S., Hu L.T., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345 2 (2001) 85-92
50. Ramsey A.H., Belongia E.A., Gale C.M., et al. Outcomes of treated human granulocytic ehrlichiosis cases. Emerg Infect Dis 8 4 (2002) 398-401
51. Klempner M.S., Wormser G.H., Wade K., et al. A case-control study to examine HLA haplotype associations in patients with post-treatment chronic Lyme disease. J Infect Dis 192 6 (2005) 1010-1013
52. Massarotti E.M., Luger S.W., Rahn D.W., et al. Treatment of early Lyme disease. Am J Med 92 4 (1992) 396-403
53. Luft B.J., Luger S.W., Rahn D.W., et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med 124 9 (1996) 785-791
54. Nadelman R.B., Luger S.W., Frank E., et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med 117 4 (1992) 273-280
55. Shadick N.A., Phillips C.B., Sangha O., et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 131 12 (1999) 919-926
56. Aguero-Rosenfeld M.E., et al. Diagnosis of lyme borreliosis. Clin Microbiol Rev 18 3 (2005) 484-509
57. Wilske B., Fingerle V., and Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49 1 (2007) 13-21
58. Phillips S.E., Mattman L.H., Hulinska D., et al. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infection 26 6 (1998) 364-367
59. Marques A.R., Stock F., and Gill V. Evaluation of a new culture medium for Borrelia burgdorferi. J Clin Microbiol 38 11 (2000) 4239-4241
60. Tilton R.C., Barden D., and Sand M. Culture Borrelia burgdorferi. J Clin Microbiol 39 7 (2001) 2747
61. Bayer M.E., Zhang L., and Bayer M.H. Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases. Infection 24 5 (1996) 347-353
62. Fleming R.V., Marques A.R., Klempner M.S., et al. Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 8 (2004) 615-618
63. Marques A.R., Hornung R.L., Dally L., et al. Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi. Clin Diagn Lab Immunol 12 9 (2005) 1036-1040
64. Straubinger R.K., Summers B.A., Chang Y.F., et al. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 35 1 (1997) 111-116
65. Straubinger R.K. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J Clin Microbiol 38 6 (2000) 2191-2199
66. Bockenstedt L.K., Mao J., Hodzic E., et al. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J Infect Dis 186 10 (2002) 1430-1437
67. Yrjanainen H., Hytonen J., Song X.Y., et al. Antitumor necrosis factor-α treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice. J Infect Dis 195 10 (2007) 1489-1496
68. Cameron D.J. Generalizability in two clinical trials of Lyme disease. Epidemiol Perspect Innov 3 (2006) 12
69. Stricker R.B. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 45 2 (2007) 149-157
70. Donta S.T. Lyme disease guidelines-it's time to move forward. Clin Infect Dis 44 8 (2007) 1134-1135 author reply 1137-9
71. Donta S.T. Tetracycline therapy for chronic Lyme disease. Clin Infect Dis 25 Suppl 1 (1997) S52-S56
72. Donta S.T. Macrolide therapy of chronic Lyme Disease. Med Sci Monit 9 11 (2003) PI136-PI142
73. Schunemann H.J., Fretheim A., and Oxman A.D. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Policy Syst 4 (2006) 21
74. Sackett D.L., Rosenberg W.M., Gray J.A., et al. Evidence-based medicine: what it is and what it isn't. BMJ 312 7023 (1996) 71-72
75. Burdge D.R., and O'Hanlon D.P. Experience at a referral center for patients with suspected Lyme disease in an area of nonendemicity: first 65 patients. Clin Infect Dis 16 4 (1993) 558-560
76. Seidel M.F., Domene A.B., and Vetter H. Differential diagnoses of suspected Lyme borreliosis or post-Lyme disease syndrome. Eur J Clin Microbiol Infect Dis 26 9 (2007) 611-617
77. Luger S.W., Paparone P., Wormser G.P., et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother 39 3 (1995) 661-667
78. Barsic B., Maretic T., Majerus L., et al. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection 28 3 (2000) 153-156